A common ancestor for selecting all of the news
Stronger Earnings And Higher BRIUMVI Guidance Might Change The Case For Investing In TG Therapeutics (TGTX)
SWI Editorial Staff2026-05-14T00:44:55-07:00TG Therapeutics recently reported past first-quarter 2026 results showing revenue of US$204.92 million and net income of US$19.78 million, while raising its full-year 2026 total global revenue target to about ...









